BROWN L F,DETMAR M,CLAFFEY K,et al.Vascular perme ability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine[J].Regulation of Angiogenesis,1997,79(2):233-269.
[2]
ASANO M,YUKITA A,MATSUMOTO T,et al.Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121[J].Cancer Research,1995(55):5296-5302.
[3]
SHINKARUK S,BAYLE M,LAIN G,et al.Vascular endothelial cell growth factor(VEGF): An emerging target for cancer chemotherapy[J].Current Medicinal Chemistry-Anti-Cancer Agents,2003,3(2):95-117.
[4]
ARKONAC B M,FOSTER L C,SIBINGA N E,et al.Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells[J].Journal of Biological Chemistry,1998,273(8):4400-4405.
HSU J Y,WAKELEE H A.Monoclonal antibodies targeting vascular endothelial growth factor: Current status and future challenges in cancer therapy[J].BioDrugs,2009,23(5):289-304.
PARIKH S S,MEHTAL H H,DESAI B I.Advances in development of bevacizumab a humanized antiangiogenic therapeutic monoclonal antibody targeting VEGF in cancer cells[J].International Journal of Pharmacy and Biomedical Sciences,2012,3(4):155-163.
